Seroconversion in asymptomatic COVID-19 pediatric patients with rheumatic diseases of one tertiary referral hospital

Simon, Juliana R.; Pereira, Maria F. B.; Marques, Heloisa H.; Elias, Adriana M.; Sakita, Neusa K.; Ferreira, Juliana C. O. A.; Precioso, Alexander Roberto; Grisi, Sandra J. F. E.; Ferrer, Ana Paula S.; Bain, Vera; Silva, Clovis A.; Campos, Lúcia M. A..
Clinics, v. 77, 100110, set. 2022
Artigo em Inglês | SES-SP, SESSP-IBPROD, SES-SP | ID: bud-4560

Documentos relacionados

  1. Seroconversion in asymptomatic COVID-19 pediatric patients with rheumatic diseases of one tertiary referral hospital
  2. Seroconversion in asymptomatic COVID-19 pediatric patients with rheumatic diseases of one tertiary referral hospital.
  3. [Classical antihypertensive drugs: diuretics].
  4. [Tapering of psychotropic drugs: current practice and needs of patients and their relatives].
  5. Inhaled corticosteroids for the treatment of COVID-19.
  6. DIABETES MELLITUS IN COVID-19 PATIENTS: VERDICT OR NOT?
  7. Real-world effectiveness of steroids in severe COVID-19: a retrospective cohort study.
  8. Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.
  9. Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review.
  10. Post-COVID Syndrome: The Stranger Ghost of Culprit COVID-19.